Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Smith & Nephew Snats ADR (SNN)

Smith & Nephew Snats ADR (SNN)
25.81 -0.50 (-1.90%) 10:23 ET [NYSE]
25.40 x 200 25.43 x 700
Realtime by (Cboe BZX)
25.40 x 200 25.43 x 700
Realtime 25.24 -1.07 (-4.07%) 09:27 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
25.10
Day High
25.47
Open 25.22
Previous Close 26.31 26.31
Volume 159,558 159,558
Avg Vol 798,607 798,607
Stochastic %K 3.99% 3.99%
Weighted Alpha -0.16 -0.16
5-Day Change -3.05 (-10.75%) -3.05 (-10.75%)
52-Week Range 23.65 - 31.72 23.65 - 31.72
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,502,679
  • Shares Outstanding, K 437,198
  • Annual Sales, $ 5,810 M
  • Annual Income, $ 412,000 K
  • EBIT $ 0 M
  • EBITDA $ 1,302 M
  • 60-Month Beta 0.71
  • Price/Sales 2.10
  • Price/Cash Flow 8.85
  • Price/Book 2.32

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 35.70%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.12 +0.80%
on 04/07/25
Period Open: 29.86
30.07 -15.78%
on 03/10/25
-4.54 (-15.20%)
since 03/07/25
3-Month
23.69 +6.88%
on 01/14/25
Period Open: 24.61
30.41 -16.74%
on 03/05/25
+0.71 (+2.89%)
since 01/07/25
52-Week
23.65 +7.06%
on 04/16/24
Period Open: 24.47
31.72 -20.18%
on 09/09/24
+0.85 (+3.47%)
since 04/05/24

Most Recent Stories

More News
Zimmer Biomet Focuses on Innovation Amid Growing Competition

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting advancements...

ZBH : 105.83 (-1.41%)
SNN : 25.81 (-1.90%)
SYK : 345.82 (+0.01%)
JNJ : 150.28 (-1.93%)
SNN Stock May Gain Following the Co-Marketing Deal With JointVue

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently...

SNN : 25.81 (-1.90%)
BSX : 91.00 (+1.45%)
BAX : 28.40 (-1.35%)
DVA : 148.18 (-0.88%)
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System

Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions,...

ZBH : 105.83 (-1.41%)
SNN : 25.81 (-1.90%)
SYK : 345.82 (+0.01%)
MDT : 83.34 (+0.56%)
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

/PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports...

SNN : 25.81 (-1.90%)
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

/CNW/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine,...

SNN : 25.81 (-1.90%)
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.

BSX : 91.00 (+1.45%)
CNC : 61.05 (-1.42%)
HUM : 250.23 (-1.39%)
ISRG : 459.68 (+1.79%)
THC : 120.83 (+0.40%)
UNH : 517.48 (-1.44%)
SGRY : 20.57 (-2.56%)
ZBH : 105.83 (-1.41%)
ELV : 421.11 (-1.81%)
HCA : 328.04 (-1.09%)
SNN : 25.81 (-1.90%)
Smith+Nephew announces 510(k) clearance of its AETOSâ„¢ Shoulder System for anatomic and reverse shoulder replacement

/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States...

SNN : 25.81 (-1.90%)
Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty

/PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORIâ„¢ Digital Tensioner - a purpose built...

SNN : 25.81 (-1.90%)
3 Healthcare Dividend Payers With Big Price Growth

Sanofi, AstraZeneca and Smith & Nephew all boast price performance better than about 80% of the broader market, and all are dividend payers. 

SNY : 51.38 (-1.15%)
AZN : 66.12 (-3.42%)
SNN : 25.81 (-1.90%)
Stocks Move Higher Before the Open as Market Sentiment Improves, U.S. Inflation Data on Tap

June S&P 500 futures (ESM23) are up +0.21%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.28% this morning as market participants continued to assess the path of Federal Reserve monetary policy...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
CAT : 282.62 (-1.90%)
WDC : 31.15 (+2.00%)
MU : 67.30 (+3.99%)
AAPL : 185.40 (-1.58%)
JPM : 211.30 (+0.49%)
WFC : 60.97 (-0.02%)
C : 58.33 (+0.34%)
CINE.LN : 0.381 (unch)
TLRY : 0.5731 (-3.23%)
HEXO : 0.7100 (+2.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative...

See More

Key Turning Points

3rd Resistance Point 27.65
2nd Resistance Point 27.36
1st Resistance Point 26.84
Last Price 25.81
1st Support Level 26.03
2nd Support Level 25.74
3rd Support Level 25.22

See More

52-Week High 31.72
Fibonacci 61.8% 28.64
Fibonacci 50% 27.68
Fibonacci 38.2% 26.73
Last Price 25.81
52-Week Low 23.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades